atomoxetine hydrochloride · Lilly · NDA 021411

Strattera

Earliest generic entry, as listed · earliest of 7 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

  • 25 Oct 2026Generic approved · 021411-002

Products covered · 8

NDA · productFormStrengthListed expiry
021411 · 001 · discontinuedcapsule, oralEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
021411 · 002 · RLD · discontinuedcapsule, oralEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
021411 · 003 · RLD · discontinuedcapsule, oralEQ 18MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
021411 · 004 · RLD · discontinuedcapsule, oralEQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
021411 · 005 · RLD · discontinuedcapsule, oralEQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
021411 · 006 · RLD · discontinuedcapsule, oralEQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
021411 · 007 · RLD · discontinuedcapsule, oralEQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
021411 · 008 · RLD · discontinuedcapsule, oralEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open